U.S. markets close in 3 hours 13 minutes
  • S&P 500

    3,848.74
    +19.40 (+0.51%)
     
  • Dow 30

    31,217.88
    -184.13 (-0.59%)
     
  • Nasdaq

    13,313.38
    +193.95 (+1.48%)
     
  • Russell 2000

    2,224.38
    +24.21 (+1.10%)
     
  • Crude Oil

    62.33
    -1.20 (-1.89%)
     
  • Gold

    1,722.30
    -53.10 (-2.99%)
     
  • Silver

    26.33
    -1.35 (-4.88%)
     
  • EUR/USD

    1.2085
    -0.0102 (-0.83%)
     
  • 10-Yr Bond

    1.4960
    -0.0220 (-1.45%)
     
  • GBP/USD

    1.3945
    -0.0068 (-0.49%)
     
  • USD/JPY

    106.6400
    +0.4100 (+0.39%)
     
  • BTC-USD

    47,708.90
    -3,330.51 (-6.53%)
     
  • CMC Crypto 200

    956.16
    +23.02 (+2.47%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PROG, LX and ODT

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / October 19, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Progenity, Inc. (NASDAQ: PROG)
This lawsuit is on behalf of all purchasers of Progenity common stock pursuant and/or traceable to the registration statement, as amended, issued in connection with Progenity's June 2020 initial public offering.
Lead Plaintiff Deadline: October 27, 2020

Progenity, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) that Progenity had overbilled government payors by $10.3 million in 2019 and early 2020 and, thus, had materially overstated its revenues, earnings and cash flows from operations for the historical financial periods provided in the registration statement; (ii) that Progenity would need to refund this overpayment in the second quarter of 2020 (the same quarter in which the initial public offering was conducted), adversely impacting its quarterly results; and (iii) that Progenity was suffering from accelerating negative trends in the second quarter of 2020 with respect to the Company's testing volumes, revenues and product pricing.

Learn about your recoverable losses in PROG: http://www.kleinstocklaw.com/pslra-1/progenity-inc-loss-submission-form?id=10291&from=1

Lexinfintech Holdings, Ltd. (NASDAQ: LX)
This lawsuit is on behalf of shareholders who purchased or otherwise acquired: (a) Lexin American depositary shares pursuant and/or traceable to the Company's initial public offering conducted on or about December 21, 2017; or (b) Lexin securities between December 21, 2017 and August 24, 2020.
Lead Plaintiff Deadline: November 9, 2020

The LX lawsuit alleges that Lexinfintech Holdings, Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) LexinFintech reported artificially low delinquency rates by giving borrowers in default new funds to make payments; (2) the Company's business model exposes shareholders to enormous losses by prioritizing Chinese lenders for off-balance sheet loans; (3) the Company exaggerated its user base; (4) the Company was facilitating direct peer to peer lending contrary to Chinese law; (5) the Company engaged in undisclosed related party transactions; (6) the Company lacked adequate internal controls; and (7) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in LX: http://www.kleinstocklaw.com/pslra-1/lexinfintech-holdings-ltd-loss-submission-form?id=10291&from=1

Odonate Therapeutics, Inc. (NASDAQ: ODT)
Class Period: December 7, 2017 - April 21, 2020
Lead Plaintiff Deadline: November 16, 2020

Throughout the class period, Odonate Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's orally administered chemotherapy agent, tesetaxel, was not as safe or well-tolerated as the Company had led investors to believe; (ii) consequently, tesetaxel's commercial viability as a cancer treatment was overstated; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in ODT: http://www.kleinstocklaw.com/pslra-1/odonate-therapeutics-inc-loss-submission-form?id=10291&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/611245/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-PROG-LX-and-ODT